featured

See the new paper in AAC evaluating ID-ODS in critically ill patients…

See the new paper in AAC evaluating ID-ODS in critically ill patients…

Pharmacodynamic target attainment for cefepime, meropenem and piperacillin/tazobactam using a pk/pd-based dosing calculator in critically ill patients is now published online ahead of print in AAC.

More

ID – ODS featured in The Lancet Infectious Diseases

ID – ODS featured in The Lancet Infectious Diseases

ID – ODS, our state of the art system for Bayesian analysis and Monte Carlo Simulation, is featured in a review article published in The Lancet Infectious Diseases, the journal with the highest Impact Factor in the field of infectology around the world!

More

ID – ODS for Apple, Android and Windows Desktop!

ID – ODS for Apple, Android and Windows Desktop!

Individually Designed Optimum Dosing Strategies, or ID – ODS, the simulation resource tool with extensive model library built from population pharmacokinetic models published in high quality, peer reviewed literature is now available for all mobile devices and Windows desktop.

More